Cory has been a professional trader for two decades. In addition to trading and investing he's widely published and coaches individual clients on the finer points of gaining an edge in the market.

Raise large amounts of capital with an initial public offering, burn cash while navigating clinical trials, then submit a new ...

We recently compiled a list of the 15 Best Biotech Stocks to Buy According to Billionaires. In this article, we are going to take a look at where Natera, Inc. (NASDAQ:NTRA) stands against other ...

We recently compiled a list of the 15 Best Biotech Stocks to Buy According to Billionaires. In this article, we are going to ...

We recently published a list of the 12 Best Biotech Penny Stocks To Invest In Now. In this article, we are going to take a look at where Ardelyx, Inc. (NASDAQ:ARDX) stands against the other best ...

Over the past five years, Celgene (NASDAQ: CELG) stock has soared 280%. That's better than any other biotech with a market cap of $50 billion or more. Celgene's past success stemmed primarily from ...

AI is rewriting biotech’s commercial playbook—cutting waste, shrinking teams, and giving first‑time drugmakers a faster, smarter path to launch.

Investing in biotech stocks isn't for everyone. An unsuccessful clinical trial can cause a huge decline. The competition is usually fierce. Volatility is almost always present. However, some biotech ...

Biotech firms like Axsome and BioNTech develop innovative treatments, offering growth potential for investors. Strong financial positions reduce risk in biotech investing, prioritizing firms with both ...

Goldman Sachs has spotlighted an often-overlooked sector poised to benefit from lower borrowing costs: biotechnology stocks. In a recent note to clients, John Flood, Goldman’s Head of Americas ...